palbociclib
pfizer,medsir
['pallas', 'palbociclib', 'breast', 'medsir']
does the bmi impact patients with hr+ early breast cancer receiving endocrine therapy +/- palbociclib?
-preplanned analysis of pallas trial shows overweight pts had lower rates of g3-4 neutropenia &amp; discontinuations
-no apparent differential effect on idfs
#asco22 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc